Cargando…
Considerations for managing chronic obstructive pulmonary disease in the elderly
Chronic obstructive pulmonary disease (COPD) is common in older people, with an estimated prevalence of 10% in the US population aged ≥75 years. Inhaled medications are the cornerstone of treatment for COPD and are typically administered by one of three types of devices, ie, pressurized metered dose...
Autores principales: | Taffet, George E, Donohue, James F, Altman, Pablo R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864989/ https://www.ncbi.nlm.nih.gov/pubmed/24376347 http://dx.doi.org/10.2147/CIA.S52999 |
Ejemplares similares
-
Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium
por: Beeh, Kai-Michael, et al.
Publicado: (2012) -
A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
por: D’Urzo, Anthony, et al.
Publicado: (2015) -
Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
por: Donohue, James F, et al.
Publicado: (2011) -
Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis
por: Donohue, James F, et al.
Publicado: (2017) -
Lung transplantation in chronic obstructive pulmonary disease: patient selection and special considerations
por: Lane, C Randall, et al.
Publicado: (2015)